Salarius Pharmaceuticals, Inc. — Director's Dealing 2015

Jan 30, 2015

SEC Form 3/A — Form 3/A

Issuer: Flex Pharma, Inc. (FLKS)
CIK: 0001615219
Period of Report: 2015-01-28

Reporting Person: Longwood Fund II, L.P. (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Preferred Stock	$		Common Stock (8000000)		Direct
Series B Preferred Stock	$		Common Stock (2212756)		Direct

Footnotes

F1: N/A.

F2: The shares have no expiration date.

F3: The shares will automatically convert on a 4.2825-for-1 basis into shares of the Issuer's Common Stock immediately upon the closing of a Qualified Public Offering (as defined in the Amended and Restated Certificate of Incorporation) as filed with the State of Delaware.